Cargando…

Homozygous YME1L1 mutation causes mitochondriopathy with optic atrophy and mitochondrial network fragmentation

Mitochondriopathies often present clinically as multisystemic disorders of primarily high-energy consuming organs. Assembly, turnover, and surveillance of mitochondrial proteins are essential for mitochondrial function and a key task of AAA family members of metalloproteases. We identified a homozyg...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hartmann, Bianca, Wai, Timothy, Hu, Hao, MacVicar, Thomas, Musante, Luciana, Fischer-Zirnsak, Björn, Stenzel, Werner, Gräf, Ralph, van den Heuvel, Lambert, Ropers, Hans-Hilger, Wienker, Thomas F, Hübner, Christoph, Langer, Thomas, Kaindl, Angela M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	eLife Sciences Publications, Ltd 2016
Materias:	Human Biology and Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4991934/ https://www.ncbi.nlm.nih.gov/pubmed/27495975 http://dx.doi.org/10.7554/eLife.16078

Ejemplares similares

ROMO1 is a constituent of the human presequence translocase required for YME1L protease import
por: Richter, Frank, et al.
Publicado: (2019)

Loss of the mitochondrial i‐AAA protease YME1L leads to ocular dysfunction and spinal axonopathy
por: Sprenger, Hans‐Georg, et al.
Publicado: (2018)

Homozygous ARHGEF2 mutation causes intellectual disability and midbrain-hindbrain malformation
por: Ravindran, Ethiraj, et al.
Publicado: (2017)

The Role of a Novel TRMT1 Gene Mutation and Rare GRM1 Gene Defect in Intellectual Disability in Two Azeri Families
por: Davarniya, Behzad, et al.
Publicado: (2015)

Biallelic mutations in the ferredoxin reductase gene cause novel mitochondriopathy with optic atrophy
por: Peng, Yanyan, et al.
Publicado: (2017)

Biallelic mutations in the ferredoxin reductase gene cause novel mitochondriopathy with optic atrophy
por: Peng, Yanyan, et al.
Publicado: (2018)

Mitochondrial Medicine and the Neurodegenerative Mitochondriopathies
por: Swerdlow, Russell H.
Publicado: (2009)

Evaluating information content of SNPs for sample-tagging in re-sequencing projects
por: Hu, Hao, et al.
Publicado: (2015)

Metabolism and Innate Immunity Meet at the Mitochondria
por: Bahat, Amir, et al.
Publicado: (2021)

Mutations in PTRH2 cause novel infantile-onset multisystem disease with intellectual disability, microcephaly, progressive ataxia, and muscle weakness
por: Hu, Hao, et al.
Publicado: (2014)

The i-AAA protease YME1L and OMA1 cleave OPA1 to balance mitochondrial fusion and fission
por: Anand, Ruchika, et al.
Publicado: (2014)

Chromium and cobalt intoxication mimicking mitochondriopathy
por: Rattay, Tim W., et al.
Publicado: (2021)

Loss of Yme1L perturbates mitochondrial dynamics
por: Ruan, Y, et al.
Publicado: (2013)

Molecular oncology focus - Is carcinogenesis a 'mitochondriopathy'?
por: Czarnecka, Anna M, et al.
Publicado: (2010)

Zonisamide Ameliorates Microglial Mitochondriopathy in Parkinson’s Disease Models
por: Tada, Satoshi, et al.
Publicado: (2022)

ThYme: a database for thioester-active enzymes
por: Cantu, David C., et al.
Publicado: (2011)

Atherosclerosis as Mitochondriopathy: Repositioning the Disease to Help Finding New Therapies
por: Shemiakova, Taisiia, et al.
Publicado: (2021)

Impaired OMA1-dependent cleavage of OPA1 and reduced DRP1 fission activity combine to prevent mitophagy in cells that are dependent on oxidative phosphorylation
por: MacVicar, Thomas D. B., et al.
Publicado: (2014)

Characterization of Cme and Yme thermostable Cas12a orthologs
por: Fuchs, Ryan T., et al.
Publicado: (2022)

Role of the AAA protease Yme1 in folding of proteins in the intermembrane space of mitochondria
por: Schreiner, Bernadette, et al.
Publicado: (2012)

Down‐regulation of the mitochondrial i‐AAA protease Yme1L induces muscle atrophy via FoxO3a and myostatin activation
por: Lee, Yoo Jeong, et al.
Publicado: (2019)

Cytoplasmic hybrid (cybrid) cell lines as a practical model for mitochondriopathies
por: Wilkins, Heather M., et al.
Publicado: (2014)

Paradoxical Inhibition of Glycolysis by Pioglitazone Opposes the Mitochondriopathy Caused by AIF Deficiency
por: Bénit, Paule, et al.
Publicado: (2017)

Mitochondrial Tim9 protects Tim10 from degradation by the protease Yme1
por: Spiller, Michael P., et al.
Publicado: (2015)

Fluorescence Methods Applied to the Description of Urea-Dependent YME1L Protease Unfolding
por: Moore, Sydney, et al.
Publicado: (2020)

Understanding the Role of Yeast Yme1 in Mitochondrial Function Using Biochemical and Proteomics Analyses
por: Kan, Kwan Ting, et al.
Publicado: (2022)

Large homozygous RAB3GAP1 gene microdeletion causes Warburg Micro Syndrome 1
por: Picker-Minh, Sylvie, et al.
Publicado: (2014)

Protection against laryngeal and pharyngeal carcinoma: Heterozygous vs. homozygous deletions of GSTM1 and GSTT1
por: Masood, Nosheen, et al.
Publicado: (2013)

Reticular Dysgenesis and Mitochondriopathy Induced by Adenylate Kinase 2 Deficiency with Atypical Presentation
por: Ghaloul-Gonzalez, Lina, et al.
Publicado: (2019)

Mitochondriopathy Manifesting as Inherited Tubulointerstitial Nephropathy Without Symptomatic Other Organ Involvement
por: Buglioni, Alessia, et al.
Publicado: (2021)

SARS-CoV-2 mitochondriopathy in COVID-19 pneumonia exacerbates hypoxemia
por: Archer, Stephen L., et al.
Publicado: (2022)

SARS-CoV-2 Mitochondriopathy in COVID-19 Pneumonia Exacerbates Hypoxemia
por: Archer, Stephen
Publicado: (2022)

Is Long COVID Syndrome a Transient Mitochondriopathy Newly Discovered: Implications of CPET
por: Sakellaropoulos, Stefanos G., et al.
Publicado: (2022)

De novo truncating mutations in ASXL3 are associated with a novel clinical phenotype with similarities to Bohring-Opitz syndrome
por: Bainbridge, Matthew N, et al.
Publicado: (2013)

Ulcerative colitis mucosal transcriptomes reveal mitochondriopathy and personalized mechanisms underlying disease severity and treatment response
por: Haberman, Yael, et al.
Publicado: (2019)

Tumor suppressor KIF1Bβ regulates mitochondrial apoptosis in collaboration with YME1L1
por: Ando, Koji, et al.
Publicado: (2019)

MPC2 variants disrupt mitochondrial pyruvate metabolism and cause an early-onset mitochondriopathy
por: Pujol, Claire, et al.
Publicado: (2022)

The C-terminal region of the oxidoreductase MIA40 stabilizes its cytosolic precursor during mitochondrial import
por: Murschall, Lena Maria, et al.
Publicado: (2020)

Imaging of the spine in patients with malignancy
por: MacVicar, David
Publicado: (2006)

Spinal and meningeal metastatic disease
por: MacVicar, D.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_cbt9vchdr4121875a0qlpl2fn7